Table: Chugai Pharm -9-MTH group results (IFRS)

Chugai Pharmaceutical

24/10/2023 09:00

Oct 24 (Reuters)- 
              Chugai Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   9 months ended      9 months ended       Year to 
                  Sep 30, 2023        Sep 30, 2022     Dec 31, 2023 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales              837.56              821.23                     
                   (+2.0 pct)                                       
  Operating          317.60              383.84                     
                   (-17.3 pct)         (+35.7 pct)                  
  Pretax
  Net                234.27              271.95                     
                   (-13.9 pct)         (+33.2 pct)                  
  EPS Basic        142.40 yen          165.35 yen                   
  EPS Diluted      142.37 yen          165.29 yen                   
  Ann Div                               78.00 yen        80.00 yen  
  -Q2 Div           40.00 yen           38.00 yen                   
  -Q4 Div                               40.00 yen        40.00 yen  
 
  NOTE - Chugai Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4519.T